Materials • Specialty Chemicals
$2.95 ▲ +0.02
(+0.82%)
MKT CAP: $7.7M • VOL: 83.6K
52W L $2 52W H $6
YHGJ // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $19.7M | $18.0M | $0 |
| YoY Revenue Growth % | — | — | — |
| Gross Profit | $3.6M | $3.6M | — |
| Gross Margin % | 18.2% | 20.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$2.0M | -$612.0K | -$399.0K |
| Operating Margin % | -10.4% | -3.4% | — |
| Net Income (GAAP) | -$2.5M | -$1.5M | -$235.0K |
| EBITDA (Normalized) | — | -$347.2K | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$172.0K | -$1.3M | -$1.2M |
| Capital Expenditures (CapEx) | — | $331.0K | — |
| Free Cash Flow (FCF) | -$172.0K | -$1.6M | -$1.2M |
| FCF Margin % | -0.9% | -8.9% | — |
| Return on Invested Capital (ROIC %) | -19.1% | -4.6% | — |
| Cash & Short-Term Equivalents | $97.0K | $220.0K | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $8.6M | $10.7M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR YHGJ.